A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

Australia

The Children's Hospital of Westmead, Sydney, New South Wales

Canada

BC Children's Hospital, Vancouver, British Columbia